A dataset containing predictions for chemo-censitivity and pathological response from Hatzis (2011)
data(df)validate: Validation status
drfs: Censoring status; 0=censored, 1=event.
drfs.time: Time to event or censoring
er.status: ER status, P=positive, N=negative
chemo.pred: Prediction for chemo sensitivity from the ACES predictor, sensitive or insensitive
pre.N: Prediction of nodal status
pCR.RD: pathological complete response (pCR) or residual disease (RD)
pre.grade: prediction of tumor grade
pre.T: T stage prediction
dlda30: DLDA30 prediction for the pathological response.
[1] Hatzis, C., Pusztai, L., Valero, V., Booser, D. J., Esserman, L., Lluch, A., et al. (2011). A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. The Journal of the American Medical Association 305, 1873<U+2013>1881.